7-10 October 2023
36th European College of Neuropsychopharmacology congress (ECNP 2023)
Centre Convencions Internacional de Barcelona (CCIB)
Barcelona
Spain
Poster title: “PORTICO – Double-blind, randomized placebo-controlled, adaptive phase IIb trial with vafidemstat in borderline personality disorder – aggregated baseline characteristics, demographics and safety”
Presenter: Dr. Michael Ropacki, Oryzon’s CMO for CNS